Cohort study of new off-label gabapentin prescribing in chronic opioid users.

Jessica I Billig Mark C BicketMaryam YazdanfarVidhya GunaseelanErika D SearsChad M BrummettJennifer F Waljee

Published in: Regional anesthesia and pain medicine (2023)

In this study of patients with chronic opioid use, an off-label gabapentin prescription did not reduce opioid dosage in the majority of patients. The coprescribing of these medications should be critically evaluated to ensure optimal patient safety.

Keyphrases

patient safety
end stage renal disease
chronic pain
pain management
ejection fraction
quality improvement
neuropathic pain
newly diagnosed
chronic kidney disease
primary care
peritoneal dialysis
prognostic factors
emergency department
adverse drug